Register entry
Bamboo US Bidco LCC
- Registered sites
- 0
- Drug products
- 26
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
26Showing 26 of 26.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Busulfan | INJECTION | DRUG FOR FURTHER PROCESSING |
| CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTION, POWDER, FOR SOLUTION | ANDA |
| CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTION, POWDER, FOR SOLUTION | ANDA |
| CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTION, POWDER, FOR SOLUTION | ANDA |
| - | Datopotamab Deruxtecan | INJECTION | DRUG FOR FURTHER PROCESSING |
| MESNEX | mesna | INJECTION, SOLUTION | NDA |
| - | Rituximab-abbs | INJECTION, SOLUTION, CONCENTRATE | DRUG FOR FURTHER PROCESSING |
| - | Rituximab-abbs | INJECTION, SOLUTION, CONCENTRATE | DRUG FOR FURTHER PROCESSING |
| - | brentuximab vedotin | POWDER, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | choriogonadotropin alfa | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | enfortumab vedotin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | enfortumab vedotin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | lurbinectedin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | mecasermin | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | mecasermin | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | paclitaxel | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION | DRUG FOR FURTHER PROCESSING |
| - | rituximab-arrx | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | rituximab-arrx | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | rituximab-arrx | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | rituximab-arrx | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | temozolomide | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | tisotumab vedotin | INJECTION, POWDER, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | tisotumab vedotin | INJECTION, POWDER, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | trastuzumab deruxtecan | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | zolbetuximab | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | zolbetuximab | INJECTION | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.